Overview
Hereditary epidermolysis bullosa (EB) associated with ocular features is a rare genetic skin condition that has been reclassified and is now considered obsolete as a standalone diagnosis in some medical databases. This means that the condition has been reorganized under other, more specific forms of epidermolysis bullosa. Epidermolysis bullosa refers to a group of inherited disorders where the skin is extremely fragile and blisters easily from minor friction, rubbing, or even without any obvious cause. In some forms of EB, the eyes can also be affected, leading to problems such as corneal erosions (painful scratches on the surface of the eye), scarring of the eye surface, and vision difficulties. Patients with these forms of EB typically develop skin blistering at birth or in early infancy. The blisters can occur anywhere on the body, including inside the mouth and on the hands and feet. When the eyes are involved, patients may experience recurring eye pain, tearing, sensitivity to light, and blurred vision. Over time, repeated eye injuries can lead to scarring that may permanently affect sight. Treatment is mainly supportive and focuses on wound care, preventing infections, protecting the skin from trauma, and managing eye complications with the help of an ophthalmologist. There is currently no cure for any form of epidermolysis bullosa, though research into gene therapy and other advanced treatments is ongoing. Early and coordinated care from a team of specialists can significantly improve quality of life.
Key symptoms:
Fragile skin that blisters easilySkin blisters from minor rubbing or frictionOpen sores and wounds on the skinCorneal erosions (painful scratches on the eye surface)Eye pain and tearingSensitivity to lightBlurred vision or vision lossScarring of the skinScarring on the eye surfaceBlisters inside the mouthDifficulty eating or swallowingNail abnormalities or nail lossItching or burning sensation on the skinSkin infections from open wounds
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features.
Start the conversation →Latest news about OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features
No recent news articles for OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific subtype of epidermolysis bullosa does my child or I have, and what gene is involved?,How often should we see an ophthalmologist to monitor for eye complications?,What is the best wound care routine to prevent infections and minimize scarring?,Are there any clinical trials or new treatments we should consider?,What signs of infection or eye emergency should prompt us to seek immediate care?,How can we manage pain effectively on a daily basis?,Are there genetic counseling services available to help us understand the risk for future children?
Common questions about OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features
What is OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features?
Hereditary epidermolysis bullosa (EB) associated with ocular features is a rare genetic skin condition that has been reclassified and is now considered obsolete as a standalone diagnosis in some medical databases. This means that the condition has been reorganized under other, more specific forms of epidermolysis bullosa. Epidermolysis bullosa refers to a group of inherited disorders where the skin is extremely fragile and blisters easily from minor friction, rubbing, or even without any obvious cause. In some forms of EB, the eyes can also be affected, leading to problems such as corneal eros
At what age does OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features typically begin?
Typical onset of OBSOLETE: Hereditary epidermolysis bullosa associated with ocular features is neonatal. Age of onset can vary across affected individuals.